Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03464396 · ClinicalTrials.gov registry record
Prematurity-Related Ventilatory Control
A clinical trial of Respiratory Control in Premature Infants, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- 177
- Enrollment target
- 1
- Study location
NCT03464396: Completed study of Respiratory Control in Premature Infants, sponsored by Washington University School of Medicine.
NCT03464396 is a study of Respiratory Control in Premature Infants that has completed, run by Washington University School of Medicine. The registered enrollment target is 177 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03464396, a study of Respiratory Control in Premature Infants, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to improve our understanding of unstable breathing and heart blood flow patterns seen in premature infants. The investigator will use novel non-invasive measures to understand the determinants of these unstable breathing and heart flow patterns to potentially identify new therapies for their prevention.
Primary Outcome
Categorization of subjects based on physiologic Challenge Tests into one of four respiratory phenotypes.
Conditions Studied
Interventions
- OTHER Bedside Physiology study
- OTHER Carotid Body Function Test
- OTHER Room Air Challenge
- OTHER Hypoxia Challenge Test
- OTHER Effects of Nasal Cannula Flow
Study Locations (1)
Missouri
- Washington University - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2018-05-14 |
| Est. Completion | 2022-03-09 |
What the finished NCT03464396 record still lists
NCT03464396 is an observational study that tracks outcomes without assigning an intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Respiratory Control in Premature Infants appearing as the primary indexed condition, and to 5 interventions - of which Bedside Physiology study is the first listed.
NCT03464396 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT03464396 about?
NCT03464396 is a clinical study titled "Prematurity-Related Ventilatory Control". The purpose of this research study is to improve our understanding of unstable breathing and heart blood flow patterns seen in premature infants. The investigator will use novel non-invasive measures to understand the determinants of these unstable breathing and heart flow patterns to potentially id...
What is the current status of trial NCT03464396?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2018-05-14. Estimated completion is 2022-03-09.
What conditions does trial NCT03464396 study?
This clinical trial studies the following conditions: Respiratory Control in Premature Infants.
What interventions are being tested in trial NCT03464396?
The interventions under investigation include: Bedside Physiology study (OTHER), Carotid Body Function Test (OTHER), Room Air Challenge (OTHER), Hypoxia Challenge Test (OTHER), Effects of Nasal Cannula Flow (OTHER).
Who is sponsoring clinical trial NCT03464396?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03464396 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI